20:38 IST
BSE
Insolvency Petition
Vivimed Labs Insolvency Petition
Vivimed Labs Limited, currently under CIRP, has scheduled the 8th meeting of the Committee of Creditors for September 29, 2026, via audio-visual means.
Vivimed Labs Ltd
- Share price
- ₹6.28
- Market cap
- ₹52.07 Cr
- Revenue (annual)
- ₹69.99 Cr
- Net profit (annual)
- ₹-176.5 Cr
- P/E (TTM)
- -0.3×Sector 47.4×
- Promoter holding
- 7.57%-0.20% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
14:41 IST
BSE
Other Announcement
Vivimed Labs Other Announcement
Vivimed Labs is seeking a three-month extension from the Registrar of Companies to convene its Annual General Meeting for the financial year 2025-26.
16:31 IST
BSE
Other Announcement
Vivimed Labs Other Announcement
Vivimed Labs Limited, currently under corporate insolvency resolution, has announced its 7th Committee of Creditors meeting scheduled for September 10, 2026, to be held virtually.
16:40 IST
BSE
Insolvency Petition
Vivimed Labs Insolvency Petition
Vivimed Labs, undergoing CIRP, has scheduled the 6th meeting of the Committee of Creditors for August 18, 2026, as per regulatory requirements.
18:24 IST
BSE
Financial Results
Vivimed Labs Q4 FY26 Results: Net Loss of ₹147.1 Cr, Loss Widens
Vivimed Labs Ltd reported revenue from operations of ₹12 Cr (-53.1% YoY) and a net loss of ₹147.1 Cr for Q4 FY26.
- Key figure
- Net loss ₹147.1 Cr
19:56 IST
BSE
Board Meeting Date
Vivimed Labs Board Meeting Date
Vivimed Labs scheduled a board meeting on July 17, 2026. The board will consider audited financial results for the period ending March 31, 2026.